Hosted on MSN4h
This biotech’s stock could double if its treatment for major depressive disorder succeeds, says MizuhoMizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...
Rakuten Group Inc. said it’s selling about 15% of its credit card arm to Mizuho Financial Group Inc. for ¥165 billion ($1.1 ...
TOKYO (Reuters) - Japan's Mizuho Financial Group will take a 15% stake in Rakuten Group subsidiary Rakuten Card for 165 ...
Mizuho analysts raised their price target for Nvidia ahead of earnings due out Nov. 20. The firm expects Nvidia to maintain ...
Japan's Seven & i Holdings is considering a management buyout that would see the 7-Eleven owner go private in a deal that ...
SMFG's net interest income is forecast to rise 17.9% to ï¿¥1.047 trillion, while that of Mizuho is projected to grow 8.0% to ...
We recently compiled a list of the 15 AI News You Missed This Week. In this article, we are going to take a look at where ...
Mizuho analysts raised their price target on semiconductor giant Nvidia (NVDA) to $165 per share, citing increased global ...
Tokyo, Nov. 13 (Jiji Press)--Mizuho Financial Group Inc. will spend about 165 billion yen to acquire a 14.99 pct stake in ...
Rakuten (JP:4755) has released an update. Rakuten Group’s subsidiary, Rakuten Card, has formed a strategic capital and business alliance with Mizuho Financial Group by transferring 14.99% of its ...
Mizuho raised the firm’s price target on Bilibili (BILI) to $21 from $17 and keeps an Outperform rating on the shares. While stimulus ...
Nvidia (NVDA) shares rose 2.7% in early trading on Tuesday as Mizuho upped its price target on the semiconductor giant. Read for more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback